Core promoter/pre-core mutations are associated with lamivudine-induced HBeAg loss in chronic hepatitis B with genotype C

Author： Asahina Y.   Izumi N.   Uchihara M.   Noguchi O.   Nishimura Y.   Inoue K.   Ueda K.   Tsuchiya K.   Hamano K.   Itakura J.   Miyake S.  

Publisher： Elsevier

ISSN： 0168-8278

Source： Journal of Hepatology, Vol.39, Iss.6, 2003-12, pp. : 1063-1069

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Interferon-Induced Anti-HBE Seroconversion Correlates with a Th1 Cytokine Shift Following Emergence of Core Promoter Mutations in Chronic Hepatitis B

By Zampino Rosa   Mangoni Emanuele   Marrone Aldo   Utili Riccardo   Ruggiero Giuseppe   Adinolfi Luigi  

Digestive Diseases and Sciences, Vol. 50, Iss. 10, 2005-10 ,pp. : 1791-1792

Springer Publishing Company

Access to resources Recommend Favorite

Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study

By Hyung Ryu S.   Chung Y.-H.   Hee Choi M.   Kim J.A.   Woo Shin J.   Kuk Jang M.   Hwa Park N.   Chu Lee H.   Sang Lee Y.   Jin Suh D.  

Journal of Hepatology, Vol. 39, Iss. 4, 2003-10 ,pp. : 614-619

Elsevier

Access to resources Recommend Favorite

Hepatitis B virus X protein (HBx)-induced apoptosis in HuH-7 cells: influence of HBV genotype and basal core promoter mutations

By Kanda T.   Yokosuka O.   Imazeki F.   Yamada Y.   Imamura T.   Fukai K.   Nagao K.   Saisho H.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 5, 2004-05 ,pp. : 478-485

Informa Healthcare

Access to resources Recommend Favorite

Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients

By Tsuge Masataka   Murakami Eisuke   Imamura Michio   Abe Hiromi   Miki Daiki   Hiraga Nobuhiko   Takahashi Shoichi   Ochi Hidenori   Nelson Hayes C.   Ginba Hiroyuki   Matsuyama Kazuhiro   Kawakami Hiroiku   Chayama Kazuaki  

Journal of Gastroenterology, Vol. 48, Iss. 10, 2013-10 ,pp. : 1188-1204

Springer Publishing Company

Access to resources Recommend Favorite

Three-year follow-up of pegylated interferon alfa-2b as monotherapy or in combination with lamivudine in patients with HBeAg-negative chronic hepatitis B

By Papadopoulos Vasileios   Protopapas Andreas   Tsianos Epameinondas   Mimidis Konstantinos  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 8, 2009-08 ,pp. : 1021-1022

Informa Healthcare

Access to resources Recommend Favorite